The document discusses pneumothorax, including its definition, pathophysiology, etiology, clinical manifestations, investigations, and management. Pneumothorax is defined as the presence of air in the pleural space. It can occur spontaneously due to ruptured blebs or bullae, or due to trauma. Clinical manifestations include dyspnea, chest pain, and decreased breath sounds on examination. Chest x-ray and CT scan are used to diagnose and characterize pneumothorax. Management involves oxygen therapy, needle aspiration, chest tube drainage, and chemical pleurodesis to promote lung re-expansion and prevent recurrence.
Pathophysiology
• Blebs andbullae are also known as emphysema-like
changes (ELCs)
• The probable cause of pneumothorax is rupture of an
apical bleb or bulla
• Because the compliance of blebs or bullae in the apices
is lower compared with that of similar lesions situated in
the lower parts of the lungs
4
5.
Pathophysiology
• It isoften hard to assess whether bullae are the site of
leakage, and where the site of rupture of the visceral
pleura is
• Smoking causes a 9-fold increase in the relative risk of a
pneumothorax in females
• A 22-fold increase in male smokers
• With a dose-response relationship between the number
of cigarettes smoked per day and occurrence of PSP
5
6.
Mechanism
• In normalpeople, the pressure in pleural space is
negative during the entire respiratory cycle.
• Two opposite forces result in negative pressure in pleural
space(outward pull of the chest wall and elastic recoil of
the lung)
• The negative pressure will be disappeared if any
communication develops .
6
7.
• When acommunication
develops between an
alveolus or other
intrapulmonary air space
and pleural space, air will
flow into the pleural space
until there is no longer a
pressure difference or the
communication is sealed
7
8.
Pathophysiology
Negative pressure eliminated
Thelung recoil-& lung-volume decrease
V/Q low –anatomic shunt
hypoxia
Positive pressure
o Compress blood vessels and heart
o Decreased cardiac output
o Impaired venous return
o Hypotension
Result in
o A decrease in vital capacity
o A decrease in PaO2
8
Primary spontaneous pneumothorax
•It occurs in young healthy individuals without
underlying lung disease.
• It is due to rupture of apical
sub-pleural bleb or bullae
Predisposing factors:
Smoking.
Tall, thin male.
Airway inflammation (distal)
Structural abnormalities of bronchial tree
Genetic contribution
10
16
Clinical type ofPNX
Pneumothorax
Closed
pneumothorax
Open
pneumothorax
Tension
pneumothorax
17.
17
Closed
pneumothorax
Open
pneumothorax
Tension
pneumothorax
The pleural tear
Issealed
The pleural tear
is open
The pleural tear
act as a ball &
valve mechanism
The pleural
cavity pressure
is < the
atmospheric
pressure
The pleural
cavity pressure
is = the
atmospheric
pressure
The pleural cavity
pressure is > the
atmospheric
pressure
18.
Clinical manifestation
• Tensionpneumothorax
o RAPIDLY PROGRESSIVE DYSPNIA.
o Cyanosis
o Marked tachycardia
o Hypotension
• Patient who suddenly deteriorate clinically,
be suspected in the patient with
o Mechanical ventilation (b/l PNX)
o Cardiopulmonary resuscitation
18
19.
Physical examination
o Dependon size of pneumothorax
o The vital signs usually normal
o Unilateral Chest movements
o The trachea may be shifted toward the contralateral side if
the pneumothorax is large
o Tactile fremitus is absent
o The percussion note is hyperresonant
o The breath sounds are reduced or absent on the affected
side
o The lower edge of the liver may be shifted inferiorly with a
right-side pneumothorax
19
Quantification of thesize
T
h
e
s
i
m
p
l
e
m
e
t
h
o
d
t
o
e
s
t
i
m
a
t
e
t
h
e
s
i
z
e
S
2424
25.
Quantification of thesize
The simple method to estimate the size
Small, a visible rim of < 2 cm between the lung margin and the chest wall
Large, a visible rim of ≥2 cm between the lung margin and chest wall
Light index
Measure transverse
Diameters of lung and
Compare it with diameter
hemithorax
2525
Hemithorax (HT)
Lung (L)
26.
26
Estimation of pneumothoraxvolume
Light equation
pneumothorax%=(1-
L3/HT3) 100
Kircher equation
pneumothorax%
Thorax area-lung area
Thorax area
Collins equation
4.2+[4.7(A+B+C)]
100
Hemithorax (HT)
Lung (L)
27.
27
A pneumothoraxof 2 cm on the PA chest
radiograph occupies about 49% of the
hemithorax volume
Lung is 8 cm, hemithorax is 10 cm in diameter
Equation
Volume of pneumothorax = (HT3 – L3) ÷ HT3
= (103 – 83) ÷ 103
= (1000 – 512) ÷1000
= 0.49
Plane chest X-ray film
DD of visceralpleural line
Skin fold:
• Positive mash band (optical edge enhancement).
• Extend beyond the chest wall.
• Lung markings extend beyond it.
CT scanning
Itis recommended in difficult cases such as
patients in whom the lungs are obscured by
overlying surgical emphysema
To differentiate a pneumothorax from suspected
bulla in complex cystic lung disease
44
U/S in pneumothorax
•Ultrasound found to be more sensitive than CXR in
diagnosis of pneumothorax.
49.
U/S signs of
pneumothorax
•Loss of lung sliding.
• Loss of comet tails.
• loss of seashore sign (M mode).
• Stratosphere sign or bar code sign(M mode).
MANAGMENT
Goals
o Topromote lung expansion
o To eliminate the pathogenesis/cause
o To decrease pneumothorax recurrence
Treatment options according to
o Classification of pneumothorax
o Pathogenesis
o The extension of lung collapse
o Severity of disease
o Complication and concomitant underlying
diseases
61
O2 TREATMENT-- PSPor SSP
68
Inhalation of high concentration of {10
l/m} oxygen may reduce the total pressure
of gases in pleural capillaries by reducing
the partial pressure of nitrogen
This should increase the pressure gradient
between the pleural capillaries and the
pleural cavity
Thereby increasing absorption of air from
the pleural cavity
60.
69
The rateof resolution/reabsorption of
spontaneous pneumothorax is
1.25 – 1.8% of volume of hemithorax
every 24 hours (ABOUT 50 DAYS TO
TAKE if 40% pnx)
The addition of high flow oxygen
therapy has been shown to result in a 4-
fold increase in the rate of
pneumothorax reabsorption during the
periods of oxygen supplementation
61.
70
Simple aspiration
Simpleaspiration is recommended as first line
treatment for all PSP requiring intervention
Simple aspiration is less likely to succeed in
secondary pneumothoraces and in this situation,
is only recommended as an initial treatment in
small (<2 cm) pneumothoraces in minimally
breathless patients under the age of 50 years
Patients should be admitted to hospital and
observed for at least 24 hours before discharge.
62.
71
Repeated aspirationis reasonable for
primary pneumothorax when the first
aspiration has been unsuccessful
A volume of < 2.5 L has been aspirated on
the first attempt
The aspiration can be done by needle or
catheter
Catheter aspiration
63.
Intercostal tube drainage
•INDICATIONS
o Tension pneumothorax
o Severe dyspnea
o Large/complete pneumothorax
o Intermittent positive pressure ventilation pneumothorax
o Recurrent pneumothorax
o Bilateral pneumothorax
o Presence of pleural fluid
o Simple aspiration or catheter aspiration drainage is unsuccessful in controlling
symptoms
72
64.
7373
A commonsite of chest tube insertion is in the
2nd ICS in mid-clavicular line.
An alternative site now commonly used is
midaxillary line of 4th and 5th intercostal
space for cosmetic reason and also for when
pleural effusion.
Intercostal tube drainage
Observation of drainage
77
No bubble released
◦ The lung re-expansion
◦ The chest tube is obstructed by secretion or blood clot
◦ The chest tube shift to chest wall, the hole of the chest
tube is located in the chest wall
If the lung re expanded, removing the chest tube 24
hours after re expansion.
Otherwise, the chest tube will be inserted again or
regulated the position.
68.
Complications of intercostaltube drainage
78
Penetration of major organs
◦ Lung, stomach, spleen, liver, heart and great vessels
◦ It occurs more commonly when a sharp metal trocar is
inappropriately applied
Pleural infection
◦ Empyema, the rate of 1%
Surgical emphysema
◦ Subcutaneous emphysema
69.
Chemical pleurodesis
79
Goals
◦To prevent pneumothorax recurrence
◦ To produce inflammation of pleura and
adhesions
Indications
◦ Persist air leak and repeated pneumothorax
◦ Bilateral pneumothorax
◦ Complicated with bullae
◦ Lung dysfunction, not tolerate to operation
70.
Chemical pleurodesis
80
Sclerosingagents
◦ Tetracycline
◦ Doxycycline
◦ Talc
◦ Erythromycin
◦ 10% povidine iodine
The instillation of sclerosing agents into the pleural
space lead to an aseptic inflammation with dense
adhesions.
71.
Chemical pleurodesis
81
Methods
◦Via chest tube or by surgical mean
◦ Administration of intrapleural local anaesthesia, 200 – 300 mg
lidocaine intrapleurally injection
◦ Agents diluted by 60 – 100 ml saline
◦ Injected to pleural space
◦ Clamp the tube 4hours
◦ Drainage again
◦ Observed by chest X-ray film, if air of pleural space is absorbed,
remove the chest tube
◦ If pneumothorax still exist, repeated pleurodesis.
Tension pneumothorax
• Itis life threatening condition.
• The pleural pressure is more than the atmospheric
pressure.
Radiological manifestations of large pneumothorax
• Mediastinal shift,
• Flattening of the hemidiaphragm &
• Lung collapse.
Associated with clinical manifestations of rapidly
progressive breathlessness and circulatory
collapse (tachycardia, hypotension & sweating).
It is more common with
• Positive pressure ventilation &
• Traumatic pneumothorax.
Failure of re-expansionof the
collapsed lung
• Due to pleural adhesions.
• Or tracheobronchial injury.
81.
93
Mediastinal andsubcutaneous emphysema
◦ Alveoli rupture, the air enter into pulmonary
interstitial, and then goes into mediastinal and
subcutaneous tissues.
◦ After aspiration or intercostal chest tube insertion, the
air enters the subcutaneous by the needle hole or
incision – surgical emphysema
◦ Physical exam – crepitus is present.
Subcutaneous
emphysema